A comparative trial of praziquantel, metrifonate and niridazole against Schistosoma haematobium.

Author: McMahonJ E

Paper Details 
Original Abstract of the Article :
Praziquantel administered in a single oral dose of 30 mg kg-1 to subjects infected with Schistosoma haematobium produced minimal side effects and was...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/00034983.1983.11811688

データ提供:米国国立医学図書館(NLM)

A New Weapon Against Schistosomiasis

Parasitic infections pose a significant threat to global health, impacting millions of people worldwide. This study focuses on schistosomiasis, a parasitic disease caused by Schistosoma haematobium, a type of flatworm that infects the urinary tract. The researchers compared the effectiveness of three different drugs against this parasite: praziquantel, metrifonate, and niridazole. Their findings reveal that praziquantel, when administered in a single oral dose, showed superior efficacy with minimal side effects, potentially revolutionizing the treatment of schistosomiasis.

Praziquantel: A Promising New Treatment

This study provides compelling evidence that praziquantel is a highly effective treatment for schistosomiasis. The researchers found that a single dose of praziquantel led to significantly higher cure rates compared to the existing treatments, metrifonate and niridazole. Furthermore, praziquantel exhibited minimal side effects, making it a potentially safer and more efficient treatment option for this debilitating disease.

Protecting Against Parasitic Infections: A Global Priority

The research highlights the need for effective treatment options for parasitic infections, particularly in regions where schistosomiasis is prevalent. Maintaining good hygiene practices, access to clean water and sanitation, and effective treatment programs are essential for combating parasitic infections and improving global health. This study offers a glimmer of hope for millions of people affected by this devastating disease.

Dr.Camel's Conclusion

Schistosomiasis, like a persistent desert wind, can blow through communities, leaving a trail of suffering. But this study brings a breath of fresh air, with the discovery of a highly effective treatment in praziquantel. It's a reminder that even in the vast desert of disease, there are opportunities for discovery and innovation, offering a path toward a healthier future.

Date :
  1. Date Completed 1983-09-20
  2. Date Revised 2019-05-16
Further Info :

Pubmed ID

6882062

DOI: Digital Object Identifier

10.1080/00034983.1983.11811688

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.